| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.18 | 0.0008 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.083 | 0.003 |